Acceptability of cell substrates for production of biologicals : report of a WHO study group [meeting held in Geneva from 18 to 19 November 1986]
Material type:
TextSeries: World Health Organization technical report series ; no. 747Publication details: Geneva : World Health Organization, 1987.Description: 29 pISBN: - 9241207477
- QW 805
| Item type | Current library | Call number | Copy number | Status | Date due | Barcode | |
|---|---|---|---|---|---|---|---|
Books
|
WHO HQ READING-RM | HQ SERIAL (Browse shelf(Opens below)) | 1 | Available | 00000693 | ||
|
Books
|
WHO HQ BORROWABLE-COLL-STACKS | QW 805 87WH (Browse shelf(Opens below)) | 2 | Withdrawn | 00000694 | ||
|
Books
|
WHO HQ ONLINE-IRIS | QW 805 87WH (Browse shelf(Opens below)) | 3 | Available | O9241207477 | ||
|
Books
|
WHO HQ ONLINE-IRIS | HQ SERIAL RUS (Browse shelf(Opens below)) | 1 | Available | O9241207477RUS |
Browsing WHO HQ shelves, Shelving location: BORROWABLE-COLL-STACKS Close shelf browser (Hides shelf browser)
Russian version of nos. 728-749 bound together (barcode no. 00073792).
A brief yet highly significant analysis of issues associated with the use of eukaryotic and prokaryotic cells in the production of biologicals. The report considers two main types of issues: first, the acceptability of developing a biological product in a new cell system when the same generic product is already being manufactured by an approved method, and second, the degree of risk associated with certain classes of possible contaminants in the product. These include heterogeneous contaminating DNA, viruses, and transforming poteins. For each contaminant, the report describes and analyses the potential risks to humans and, where appropriate, categorizes and classifies these risks. The report also advocates basic principles of manufacturing and testing that can help minimize the likelihood of risks to human recipients of products manufactured in continuous cell lines.
eng fre rus spa.
WHODOC
WHO monograph
4
There are no comments on this title.